Spero Therapeutics Inc (SPRO)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
Nov 13, 16:00
1.315
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Price to Book Value: 0.8796 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.8796 |
| November 12, 2024 | 0.8863 |
| November 11, 2024 | 0.893 |
| November 08, 2024 | 0.8863 |
| November 07, 2024 | 0.8796 |
| November 06, 2024 | 0.8796 |
| November 05, 2024 | 0.8796 |
| November 04, 2024 | 0.8661 |
| November 01, 2024 | 0.7923 |
| October 31, 2024 | 0.8258 |
| October 30, 2024 | 0.8661 |
| October 29, 2024 | 0.8796 |
| October 28, 2024 | 0.8661 |
| October 25, 2024 | 0.893 |
| October 24, 2024 | 0.846 |
| October 23, 2024 | 0.846 |
| October 22, 2024 | 0.8527 |
| October 21, 2024 | 0.8594 |
| October 18, 2024 | 0.8594 |
| October 17, 2024 | 0.8628 |
| October 16, 2024 | 0.8326 |
| October 15, 2024 | 0.8057 |
| October 14, 2024 | 0.8258 |
| October 11, 2024 | 0.8393 |
| October 10, 2024 | 0.8326 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.8326 |
| October 08, 2024 | 0.8326 |
| October 07, 2024 | 0.8728 |
| October 04, 2024 | 0.8728 |
| October 03, 2024 | 0.8661 |
| October 02, 2024 | 0.8796 |
| October 01, 2024 | 0.8796 |
| September 30, 2024 | 0.8997 |
| September 27, 2024 | 0.8796 |
| September 26, 2024 | 0.8594 |
| September 25, 2024 | 0.8594 |
| September 24, 2024 | 0.8594 |
| September 23, 2024 | 0.8728 |
| September 20, 2024 | 0.893 |
| September 19, 2024 | 0.9098 |
| September 18, 2024 | 0.8997 |
| September 17, 2024 | 0.893 |
| September 16, 2024 | 0.9198 |
| September 13, 2024 | 0.9198 |
| September 12, 2024 | 0.893 |
| September 11, 2024 | 0.8997 |
| September 10, 2024 | 0.9064 |
| September 09, 2024 | 0.9198 |
| September 06, 2024 | 0.8829 |
| September 05, 2024 | 0.893 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4053
Minimum
Jun 28 2022
6.950
Maximum
Sep 23 2021
2.385
Average
2.318
Median
Price to Book Value Benchmarks
| Arbutus Biopharma Corp | 6.471 |
| Equillium Inc | 1.232 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9398 |
Price to Book Value Related Metrics
| PE Ratio | 3.853 |
| PS Ratio | 0.6658 |
| Price | 1.31 |
| Earnings Yield | 25.95% |
| Market Cap | 70.80M |
| Operating PE Ratio | 3.365 |
| Normalized PE Ratio | 3.123 |